|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06833 SINCO PHARMA
Nominal 
0.145 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 207,586 | (232,879) | 353,700 | 75,081 |
| Net Cash from / (used in) Investing Activities | -- | (27,807) | (52,870) | (63,626) | (119,270) |
| Net Cash from / (used in) Financing Activities | -- | (236,081) | 154,587 | (189,729) | 35,043 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (56,302) | (131,162) | 100,345 | (9,146) |
| Cash & Cash Equivalents at beginning of period | -- | 308,320 | 437,922 | 329,144 | 326,052 |
| Effect of Foreign Exchange Rate Changes | -- | (2,819) | 1,560 | 8,433 | 12,238 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 249,199 | 308,320 | 437,922 | 329,144 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 19,909 |
| %Change | -18.369% |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 0.350 |